Türkiye is pioneer in treatment of “incurable” genetic diseases

Specialists of the Clinical Research Center of the Hospital at the Faculty of Medical Department of the University of Gazi in Ankara for the first time in the world introduced genetic therapy for the treatment of phenylketonuria. The disease can cause irreversible damage to the brain.

Also, university for the first time in the world has successfully introduced non -surgical intracerebral therapy – the method of genetic therapy of gangliosidosis GM1, which poses a threat to the life of children.

The correspondent of the Anadolu agency talked with the factory of children’s genetics and the deputy director of the medical institution Fatich Ezgu.

According to him, the center specializes in advanced treatment methods and research on medication, primarily for the treatment of childhood genetic diseases.

The interlocutor of the agency said that at present more than 20 clinical research is being conducted in the center.

“Our center was chosen for conducting the world’s first research in order to use genetic therapy in patients with phenylketonuria. The results of this study are important for many patients both in our country and throughout the world. At the moment, we have successfully applied genetic therapy to our two patients with phenylketonuria. In the near future it will be tested on the third patient, ”he said.

According to Fatikh Ezgu, the goal of the center’s specialists is to make the methods of treatment for all patients developed for all patients. “I would like to emphasize that patients with genetic disorders can look into the future with hope,” he said.

He added that the studies are conducted with the active support of the Ministry of Health of Turkey, the Agency for Medicines and the Medical Equipment of Turkey and the Department of Health Institutes under the Ministry of Health of the country (Tüseb).